We are live on
!
Find out more
FMI
F/M Investments Portfolio holdings
AUM
$1.51B
1-Year Est. Return
25.86%
This Fund
S&P 500
This Quarter
Est. Return
-2.84%
1 Year Est. Return
+25.86%
3 Year Est. Return
+100.08%
5 Year Est. Return
+137.58%
10 Year Est. Return
–
AUM
$2.51B
AUM Growth
-$201M
(-7.4%)
Cap. Flow
-$78.6M
Cap. Flow
% of AUM
-3.13%
Top 10 Holdings %
Top 10 Hldgs %
32.12%
Holding
422
New
23
Increased
129
Reduced
193
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Idexx Laboratories
IDXX
|
+$11.8M |
| 2 |
Citigroup
C
|
+$6.42M |
| 3 |
Blackrock
BLK
|
+$5.5M |
| 4 |
HubSpot
HUBS
|
+$4.88M |
| 5 |
Lam Research
LRCX
|
+$4.71M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$18.7M |
| 2 |
F/M 2-Year Investment Grade Corporate Bond ETF
ZTWO
|
+$18.5M |
| 3 |
Apple
AAPL
|
+$10.2M |
| 4 |
Truist Financial
TFC
|
+$9.55M |
| 5 |
TBIL
F/m US Treasury 3 Month Bill Fund
TBIL
|
+$6.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.71% |
| 2 | Healthcare | 11.09% |
| 3 | Financials | 10.98% |
| 4 | Consumer Discretionary | 8.01% |
| 5 | Industrials | 7.96% |
Similar funds
SCM
BFO
CP
RG
JFGLC
AAM
TP
KP
F/M Investments's Q1 2025 Portfolio in Review
As of Q1 2025, F/M Investments held 422 positions worth $2.51B, down 7.4% from $2.71B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
F/M Investments withdrew a net $78.6M in Q1 2025, closing 31 positions and reducing 193 holdings. Its most notable exit was Intra-Cellular Therapies Inc., an estimated $3.08M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, F/M Investments opened a new position in Idexx Laboratories worth $11.4M.
- F/M Investments's largest Q1 2025 buy was Idexx Laboratories: 27,178 shares worth $11.4M.
- F/M Investments added most to Palantir in Q1 2025, an estimated $3.23M increase.
- F/M Investments's biggest Q1 2025 reduction was UnitedHealth, cutting an estimated $18.7M.
- F/M Investments fully exited Intra-Cellular Therapies Inc. in Q1 2025, selling an estimated $3.08M.
- F/M Investments's ten largest holdings make up 32% of its $2.51B portfolio in Q1 2025.
- F/M Investments opened 23 new positions and closed 31 in Q1 2025.
- F/M Investments's portfolio value fell 7.4% quarter-over-quarter to $2.51B.
Based on F/M Investments's 13F filing for Q1 2025, filed 14 May 2025.